Dr. Reddy’s
Dr. Reddy’s Launches Affordable Semaglutide Pills in India
Dr. Reddy’s Laboratories has launched affordable semaglutide pills in India, starting at Rs 99, to improve diabetes management.
Dr Reddy’s Launches Affordable Semaglutide Pill for Diabetes Care
Dr Reddy’s Laboratories has launched semaglutide tablets in India for Rs 99, providing an affordable option for diabetes management.
Earnings Reports: Tata Power, Dr. Reddy’s, and Others Set to Release Q4 Results
On May 12, Tata Power, Dr. Reddy’s, and others will announce Q4 earnings, providing crucial insights into market trends and company performances.